nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Renal impairment—Metformin—metabolic syndrome X	0.0208	0.033	CcSEcCtD
Goserelin—Lethargy—Metformin—metabolic syndrome X	0.0202	0.032	CcSEcCtD
Goserelin—Migraine—Metformin—metabolic syndrome X	0.0195	0.0309	CcSEcCtD
Goserelin—Breast disorder—Metformin—metabolic syndrome X	0.0179	0.0284	CcSEcCtD
Goserelin—Influenza—Metformin—metabolic syndrome X	0.0171	0.0271	CcSEcCtD
Goserelin—Angina pectoris—Metformin—metabolic syndrome X	0.0167	0.0264	CcSEcCtD
Goserelin—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.0159	0.0252	CcSEcCtD
Goserelin—Drowsiness—Metformin—metabolic syndrome X	0.0153	0.0242	CcSEcCtD
Goserelin—Rhinitis—Metformin—metabolic syndrome X	0.0138	0.0218	CcSEcCtD
Goserelin—Hepatitis—Metformin—metabolic syndrome X	0.0137	0.0217	CcSEcCtD
Goserelin—GNRHR—GPCRs, Other—CNR1—metabolic syndrome X	0.0136	0.0369	CbGpPWpGaD
Goserelin—Oedema peripheral—Metformin—metabolic syndrome X	0.0135	0.0214	CcSEcCtD
Goserelin—Eye disorder—Metformin—metabolic syndrome X	0.0128	0.0203	CcSEcCtD
Goserelin—Cardiac disorder—Metformin—metabolic syndrome X	0.0127	0.0202	CcSEcCtD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—MTNR1B—metabolic syndrome X	0.0126	0.0342	CbGpPWpGaD
Goserelin—Angiopathy—Metformin—metabolic syndrome X	0.0124	0.0197	CcSEcCtD
Goserelin—Immune system disorder—Metformin—metabolic syndrome X	0.0124	0.0196	CcSEcCtD
Goserelin—Chills—Metformin—metabolic syndrome X	0.0123	0.0195	CcSEcCtD
Goserelin—Erythema—Metformin—metabolic syndrome X	0.0119	0.0189	CcSEcCtD
Goserelin—Malnutrition—Metformin—metabolic syndrome X	0.0119	0.0189	CcSEcCtD
Goserelin—Flatulence—Metformin—metabolic syndrome X	0.0118	0.0186	CcSEcCtD
Goserelin—Muscle spasms—Metformin—metabolic syndrome X	0.0115	0.0182	CcSEcCtD
Goserelin—Vision blurred—Metformin—metabolic syndrome X	0.0113	0.0178	CcSEcCtD
Goserelin—Ill-defined disorder—Metformin—metabolic syndrome X	0.0111	0.0175	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.0108	0.0293	CbGpPWpGaD
Goserelin—Malaise—Metformin—metabolic syndrome X	0.0108	0.017	CcSEcCtD
Goserelin—Palpitations—Metformin—metabolic syndrome X	0.0106	0.0167	CcSEcCtD
Goserelin—Hypertension—Metformin—metabolic syndrome X	0.0103	0.0163	CcSEcCtD
Goserelin—Chest pain—Metformin—metabolic syndrome X	0.0102	0.0161	CcSEcCtD
Goserelin—Myalgia—Metformin—metabolic syndrome X	0.0102	0.0161	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.0101	0.016	CcSEcCtD
Goserelin—Discomfort—Metformin—metabolic syndrome X	0.01	0.0159	CcSEcCtD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—HTR2C—metabolic syndrome X	0.00982	0.0267	CbGpPWpGaD
Goserelin—Oedema—Metformin—metabolic syndrome X	0.00975	0.0154	CcSEcCtD
Goserelin—Infection—Metformin—metabolic syndrome X	0.00968	0.0153	CcSEcCtD
Goserelin—Shock—Metformin—metabolic syndrome X	0.00959	0.0152	CcSEcCtD
Goserelin—Nervous system disorder—Metformin—metabolic syndrome X	0.00956	0.0151	CcSEcCtD
Goserelin—Thrombocytopenia—Metformin—metabolic syndrome X	0.00954	0.0151	CcSEcCtD
Goserelin—Skin disorder—Metformin—metabolic syndrome X	0.00947	0.015	CcSEcCtD
Goserelin—Hyperhidrosis—Metformin—metabolic syndrome X	0.00942	0.0149	CcSEcCtD
Goserelin—Anorexia—Metformin—metabolic syndrome X	0.00929	0.0147	CcSEcCtD
Goserelin—Hypotension—Metformin—metabolic syndrome X	0.00911	0.0144	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.00888	0.0141	CcSEcCtD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CNR1—metabolic syndrome X	0.00882	0.0239	CbGpPWpGaD
Goserelin—Paraesthesia—Metformin—metabolic syndrome X	0.00875	0.0139	CcSEcCtD
Goserelin—Dyspnoea—Metformin—metabolic syndrome X	0.00869	0.0138	CcSEcCtD
Goserelin—Somnolence—Metformin—metabolic syndrome X	0.00867	0.0137	CcSEcCtD
Goserelin—Dyspepsia—Metformin—metabolic syndrome X	0.00858	0.0136	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—HTR2C—metabolic syndrome X	0.0085	0.0231	CbGpPWpGaD
Goserelin—Decreased appetite—Metformin—metabolic syndrome X	0.00847	0.0134	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00841	0.0229	CbGpPWpGaD
Goserelin—Fatigue—Metformin—metabolic syndrome X	0.0084	0.0133	CcSEcCtD
Goserelin—Constipation—Metformin—metabolic syndrome X	0.00834	0.0132	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.00822	0.0223	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—GHRL—metabolic syndrome X	0.00806	0.0219	CbGpPWpGaD
Goserelin—Feeling abnormal—Metformin—metabolic syndrome X	0.00803	0.0127	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00798	0.0217	CbGpPWpGaD
Goserelin—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00797	0.0126	CcSEcCtD
Goserelin—Urticaria—Metformin—metabolic syndrome X	0.00774	0.0123	CcSEcCtD
Goserelin—Abdominal pain—Metformin—metabolic syndrome X	0.00771	0.0122	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—metabolic syndrome X	0.00761	0.0207	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00755	0.0205	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—metabolic syndrome X	0.00723	0.0196	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—metabolic syndrome X	0.00721	0.0196	CbGpPWpGaD
Goserelin—Asthenia—Metformin—metabolic syndrome X	0.00699	0.0111	CcSEcCtD
Goserelin—Pruritus—Metformin—metabolic syndrome X	0.0069	0.0109	CcSEcCtD
Goserelin—Diarrhoea—Metformin—metabolic syndrome X	0.00667	0.0106	CcSEcCtD
Goserelin—Dizziness—Metformin—metabolic syndrome X	0.00645	0.0102	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00641	0.0174	CbGpPWpGaD
Goserelin—Vomiting—Metformin—metabolic syndrome X	0.0062	0.00981	CcSEcCtD
Goserelin—Rash—Metformin—metabolic syndrome X	0.00615	0.00973	CcSEcCtD
Goserelin—Dermatitis—Metformin—metabolic syndrome X	0.00614	0.00972	CcSEcCtD
Goserelin—Headache—Metformin—metabolic syndrome X	0.00611	0.00966	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—GHRL—metabolic syndrome X	0.00607	0.0165	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00585	0.0159	CbGpPWpGaD
Goserelin—Nausea—Metformin—metabolic syndrome X	0.00579	0.00916	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—CNR1—metabolic syndrome X	0.00575	0.0156	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2C—metabolic syndrome X	0.00563	0.0153	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—MTNR1B—metabolic syndrome X	0.0055	0.015	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GHRL—metabolic syndrome X	0.00534	0.0145	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CNR1—metabolic syndrome X	0.00506	0.0137	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—AGT—metabolic syndrome X	0.00495	0.0134	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.0049	0.0133	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00465	0.0126	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL5—metabolic syndrome X	0.00446	0.0121	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—metabolic syndrome X	0.00443	0.012	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—HTR2C—metabolic syndrome X	0.00429	0.0116	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00422	0.0115	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—GHRL—metabolic syndrome X	0.00407	0.011	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.00403	0.011	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—metabolic syndrome X	0.00392	0.0106	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CNR1—metabolic syndrome X	0.00385	0.0105	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—AGT—metabolic syndrome X	0.00373	0.0101	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00362	0.00983	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—GHRL—metabolic syndrome X	0.00343	0.00932	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—HTR2C—metabolic syndrome X	0.00329	0.00893	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—metabolic syndrome X	0.00328	0.0089	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00325	0.00883	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—GHRL—metabolic syndrome X	0.00312	0.00847	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—MTNR1B—metabolic syndrome X	0.00311	0.00845	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL2—metabolic syndrome X	0.00307	0.00834	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL5—metabolic syndrome X	0.00298	0.00811	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CNR1—metabolic syndrome X	0.00295	0.00802	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—MTNR1B—metabolic syndrome X	0.00283	0.00767	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HDAC3—metabolic syndrome X	0.00279	0.00758	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—metabolic syndrome X	0.0027	0.00733	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00252	0.00684	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—AGT—metabolic syndrome X	0.0025	0.00678	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00249	0.00677	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RBP4—metabolic syndrome X	0.00243	0.0066	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TRIB3—metabolic syndrome X	0.00243	0.0066	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—HTR2C—metabolic syndrome X	0.00242	0.00658	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—GHRL—metabolic syndrome X	0.0023	0.00624	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL5—metabolic syndrome X	0.00229	0.00621	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00228	0.00619	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—HTR2C—metabolic syndrome X	0.0022	0.00598	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CNR1—metabolic syndrome X	0.00218	0.00591	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOC3—metabolic syndrome X	0.00215	0.00585	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AGT—metabolic syndrome X	0.00211	0.00572	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—GHRL—metabolic syndrome X	0.00209	0.00567	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL2—metabolic syndrome X	0.00206	0.00558	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CNR1—metabolic syndrome X	0.00198	0.00537	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HTR2C—metabolic syndrome X	0.00194	0.00528	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AGT—metabolic syndrome X	0.00191	0.0052	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CYBA—metabolic syndrome X	0.00188	0.00511	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HDAC3—metabolic syndrome X	0.00187	0.00507	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—GHRL—metabolic syndrome X	0.00184	0.005	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CNR1—metabolic syndrome X	0.00174	0.00474	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCL5—metabolic syndrome X	0.00169	0.00458	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MTNR1B—metabolic syndrome X	0.00167	0.00453	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TRIB3—metabolic syndrome X	0.00163	0.00442	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RBP4—metabolic syndrome X	0.00163	0.00442	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—metabolic syndrome X	0.00162	0.0044	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL2—metabolic syndrome X	0.00158	0.00428	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL5—metabolic syndrome X	0.00153	0.00416	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.00153	0.00414	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOC3—metabolic syndrome X	0.00144	0.00391	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF2—metabolic syndrome X	0.00143	0.00387	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AGT—metabolic syndrome X	0.00141	0.00383	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOB—metabolic syndrome X	0.00138	0.00376	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL5—metabolic syndrome X	0.00135	0.00367	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00135	0.00366	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LPL—metabolic syndrome X	0.00132	0.00359	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HTR2C—metabolic syndrome X	0.0013	0.00353	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AGT—metabolic syndrome X	0.00128	0.00348	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CYBA—metabolic syndrome X	0.00126	0.00342	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—GHRL—metabolic syndrome X	0.00123	0.00335	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CNR1—metabolic syndrome X	0.00117	0.00317	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AGT—metabolic syndrome X	0.00113	0.00307	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LEP—metabolic syndrome X	0.00111	0.00301	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOE—metabolic syndrome X	0.00111	0.00301	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—APOA1—metabolic syndrome X	0.00109	0.00297	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL2—metabolic syndrome X	0.00105	0.00287	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IRS1—metabolic syndrome X	0.000988	0.00268	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF2—metabolic syndrome X	0.000954	0.00259	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—INS—metabolic syndrome X	0.000946	0.00257	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL2—metabolic syndrome X	0.000931	0.00253	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOB—metabolic syndrome X	0.000926	0.00252	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IGF1—metabolic syndrome X	0.000915	0.00249	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL5—metabolic syndrome X	0.000905	0.00246	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000901	0.00245	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LPL—metabolic syndrome X	0.000885	0.0024	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000869	0.00236	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOS3—metabolic syndrome X	0.00083	0.00225	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AGT—metabolic syndrome X	0.000757	0.00206	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LEP—metabolic syndrome X	0.000741	0.00201	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOE—metabolic syndrome X	0.000741	0.00201	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—APOA1—metabolic syndrome X	0.000733	0.00199	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000711	0.00193	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—metabolic syndrome X	0.0007	0.0019	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IRS1—metabolic syndrome X	0.000661	0.0018	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—AKT1—metabolic syndrome X	0.000646	0.00175	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—INS—metabolic syndrome X	0.000633	0.00172	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL2—metabolic syndrome X	0.000623	0.00169	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IGF1—metabolic syndrome X	0.000613	0.00166	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SERPINE1—metabolic syndrome X	0.000582	0.00158	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOS3—metabolic syndrome X	0.000555	0.00151	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—metabolic syndrome X	0.000549	0.00149	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000476	0.00129	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—metabolic syndrome X	0.000469	0.00127	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—AKT1—metabolic syndrome X	0.000432	0.00117	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—metabolic syndrome X	0.000413	0.00112	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—AKT1—metabolic syndrome X	0.000381	0.00104	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—metabolic syndrome X	0.000367	0.000998	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—metabolic syndrome X	0.000277	0.000752	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—AKT1—metabolic syndrome X	0.000255	0.000694	CbGpPWpGaD
